FELDER; Eva

Patent Applications and Registrations

Patent applications and USPTO patent grants for FELDER; Eva.The latest application filed is for "promoters for recombinant viral expression".

Company Profile

0.28.26

FELDER; Eva - Munich DE
Felder; Eva - Munchen DE
Felder; Eva - Bavaria DE
Felder; Eva - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Promoters For Recombinant Viral Expression App 20140342403 - STEIGERWALD; Robin ; et al.	2014-11-20
Promoters for recombinant viral expression Grant 8,772,023 - Steigerwald , et al. July 8, 2	2014-07-08
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions Grant 8,673,318 - Rathe , et al. March 18, 2	2014-03-18
Modified Vaccinia Ankara virus variant and cultivation method Grant 8,470,598 - Chaplin , et al. June 25, 2	2013-06-25
Fusion proteins of HIV regulatory/accessory proteins Grant 8,435,535 - Howley , et al. May 7, 2	2013-05-07
Method For The Cultivation Of Primary Cells And For The Amplification Of Viruses Under Serum Free Conditions App 20130089913 - RATHE; INGMAR ; et al.	2013-04-11
Fusion proteins of HIV regulatory/accessory proteins Grant 8,389,275 - Howley , et al. March 5, 2	2013-03-05
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions Grant 8,329,466 - Rathe , et al. December 11, 2	2012-12-11
Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Grant 8,323,661 - Howley , et al. December 4, 2	2012-12-04
Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs) Grant 8,309,098 - Howley , et al. November 13, 2	2012-11-13
Modified Vaccinia Ankara Virus Variant And Cultivation Method App 20120276613 - CHAPLIN; PAUL ; et al.	2012-11-01
Modified Vaccinia Ankara virus variant and cultivation method Grant 8,236,560 - Chaplin , et al. August 7, 2	2012-08-07
Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs) Grant 8,198,088 - Howley , et al. June 12, 2	2012-06-12
Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs) Grant 8,197,822 - Howley , et al. June 12, 2	2012-06-12
Fusion Proteins Of Hiv Regulatory/accessory Proteins App 20120142097 - HOWLEY; Paul ; et al.	2012-06-07
Fusion Proteins Of Hiv Regulatory/accessory Proteins App 20120142096 - HOWLEY; Paul ; et al.	2012-06-07
Promoters For Recombinant Viral Expression App 20120121617 - Steigerwald; Robin ; et al.	2012-05-17
Fusion proteins of HIV regulatory/accessory proteins Grant 8,147,839 - Howley , et al. April 3, 2	2012-04-03
Fusion protein of HIV regulatory/accessory proteins Grant 8,143,054 - Howley , et al. March 27, 2	2012-03-27
Fusion proteins of HIV regulatory/accessory proteins Grant 8,137,931 - Howley , et al. March 20, 2	2012-03-20
Intergenic Regions As Novel Sites For Insertion Of Hiv Dna Sequences In The Genome Of Modified Vaccinia Virus Ankara App 20120015423 - HOWLEY; Paul ; et al.	2012-01-19
Intergenic Regions As Novel Sites For Insertion Of Hiv Dna Sequences In The Genome Of Modified Vaccinia Virus Ankara App 20120014922 - Howley; Paul ; et al.	2012-01-19
Intergenic Regions As Novel Sites For Insertion Of Hiv Dna Sequences In The Genome Of Modified Vaccinia Virus Ankara App 20120009214 - HOWLEY; Paul ; et al.	2012-01-12
Intergenic Regions As Novel Sites For Insertion Of Hiv Dna Sequences In The Genome Of Modified Vaccinia Virus Ankara App 20110306093 - HOWLEY; PAUL ; et al.	2011-12-15
Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Grant 8,029,800 - Howley , et al. October 4, 2	2011-10-04
Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Grant 8,021,669 - Howley , et al. September 20, 2	2011-09-20
Method For The Cultivation Of Primary Cells And For The Amplification Of Viruses Under Serum Free Conditions App 20110217749 - RATHE; INGMAR ; et al.	2011-09-08
Modified Vaccinia Ankara Virus Variant And Cultivation Method App 20110217757 - CHAPLIN; PAUL ; et al.	2011-09-08
Modified vaccinia ankara virus variant and cultivation method Grant 7,964,398 - Chaplin , et al. June 21, 2	2011-06-21
Modified vaccinia ankara virus variant and cultivation method Grant 7,964,395 - Chaplin , et al. June 21, 2	2011-06-21
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions Grant 7,964,397 - Rathe , et al. June 21, 2	2011-06-21
Modified vaccinia ankara virus variant and cultivation method Grant 7,964,396 - Chaplin , et al. June 21, 2	2011-06-21
Modified Vaccinia Ankara Virus Variant And Cultivation Method App 20100279386 - CHAPLIN; PAUL ; et al.	2010-11-04
Intergenic Regions As Novel Sites For Insertion Of Hiv Dna Sequences In The Genome Of Modified Vaccinia Virus Ankara App 20100196992 - HOWLEY; PAUL ; et al.	2010-08-05
Intergenic Regions As Novel Sites For Insertion Of Hiv Dna Sequences In The Genome Of Modified Vaccinia Virus Ankara App 20100183663 - HOWLEY; PAUL ; et al.	2010-07-22
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions Grant 7,695,939 - Rathe , et al. April 13, 2	2010-04-13
Fusion Proteins Of Hiv Regulatory/accessory Proteins App 20100047871 - Howley; Paul ; et al.	2010-02-25
Fusion Proteins Of Hiv Regulatory/accessory Proteins App 20100047268 - HOWLEY; Paul ; et al.	2010-02-25
Fusion Protein Of Hiv Regulatory/accessory Proteins App 20090280561 - Howley; Paul ; et al.	2009-11-12
Fusion proteins of non-attenuated HIV regulatory/accessory proteins Grant 7,569,228 - Howley , et al. August 4, 2	2009-08-04
Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara Grant 7,501,127 - Howley , et al. March 10, 2	2009-03-10
Method For The Cultivation Of Primary Cells And For The Amplification Of Viruses Under Serum Free Conditions App 20090029459 - RATHE; INGMAR ; et al.	2009-01-29
Modified Vaccinia Ankara Virus Variant And Cultivation Method App 20090017536 - Chaplin; Paul ; et al.	2009-01-15
Modified Vaccinia Ankara Virus Variant And Cultivation Method App 20080317778 - Chaplin; Paul ; et al.	2008-12-25
Modified Vaccinia Ankara virus variant and cultivation method Grant 7,445,924 - Chaplin , et al. November 4, 2	2008-11-04
Fusion proteins of HIV regulatory/accessory proteins App 20060257974 - Howley; Paul ; et al.	2006-11-16
Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of modified vaccinia virus ankara App 20060188961 - Howley; Paul ; et al.	2006-08-24
Fusion protein of hiv regulatory/accessory proteins App 20050222388 - Howley, Paul ; et al.	2005-10-06
Modified vaccinia ankara virus variant and cultivation method App 20050214323 - Chaplin, Paul ; et al.	2005-09-29
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions App 20050214324 - Rathe, Ingmar ; et al.	2005-09-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.